Iodine-131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective
Neuroblastoma, which derives from neural crest, is the most common extracranial solid cancer in childhood. The tumors express the norepinephrine (NE) transporters on their cell membrane and take in metaiodobenzylguanidine (MIBG) via a NE transporter. Since iodine-131 (I-131) MIBG therapy was firstly...
Saved in:
Main Authors: | Daiki Kayano, Seigo Kinuya |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2015/189135 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resveratrol Sensitizes Selectively Thyroid Cancer Cell to 131-Iodine Toxicity
by: Seyed Jalal Hosseinimehr, et al.
Published: (2014-01-01) -
PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy
by: Vineet Mohan MSc, et al.
Published: (2020-07-01) -
Nomogram models for predicting outcomes in thyroid cancer patients with distant metastasis receiving 131iodine therapy
by: Shui Jin, et al.
Published: (2025-01-01) -
Bacanora and Sotol: So Far, So Close
by: Alfonso A. Gardea, et al.
Published: (2012-01-01) -
Musculoskeletal ultrasound in India: Journey so far
by: Ved Chaturvedi
Published: (2018-01-01)